Pre-Award Costs Under 2 CFR 200.458

2 CFR §200.458 governs a narrow but high-risk question: can an institution spend money against a federal award before that award formally exists? This page focuses specifically on that provision — the approval mechanism, the widely-cited 90-day norm (which is agency policy layered on top of the regulation, not text written into §200.458 itself), and the institutional risk of getting it wrong. For the full allowability framework §200.458 sits inside, see 2 CFR 200 Subpart E: The Cost Principles Governing Federal Grant Costs. For the administrative requirements that apply earlier in the process — before a proposal is even submitted — see 2 CFR 200 Subpart C: Pre-Federal Award Requirements, and for how pre-award and post-award responsibilities are typically divided between offices, see Pre-Award vs. Post-Award Office Roles.

What §200.458 actually says

The regulatory text is short. Pre-award costs are costs “incurred before the start date of the Federal award or subaward directly pursuant to the negotiation and in anticipation of the Federal award where such costs are necessary for efficient and timely performance of the scope of work.” They are allowable only to the extent they would have been allowable if incurred after the start date, and only with the written approval of the Federal awarding agency. If approved, they must be charged to the initial budget period of the award, unless the agency or a pass-through entity specifies otherwise.

Two things worth noticing in that text: first, the cost still has to clear the ordinary allowability tests at §200.403 (necessary, reasonable, allocable, consistently treated) — pre-award approval doesn’t waive those, it just extends the window in which a qualifying cost can be charged. Second, the regulation itself does not specify a 90-day period, a specific approval form, or who within the agency has to sign off. Those mechanics are set by each federal awarding agency’s own implementing policy, which is why the practical answer to what can be charged, and whether it needs approval, depends heavily on which agency is funding the work.

Where the 90-day norm comes from

Most research administrators know §200.458 as the “90-day rule,” but that figure is an agency-level implementation choice, not a government-wide regulatory floor. Two of the largest federal research funders illustrate how this works in practice:

NIH: under NIH’s expanded authorities, a recipient may incur pre-award costs up to 90 calendar days before the anticipated start date of a new or renewal award without obtaining prior NIH approval, provided the institution’s own policies document that the spending was authorized and that it is necessary for the effective and timely conduct of the project. Costs incurred more than 90 days before the start date require prior written approval from the awarding NIH Institute or Center. This 90-day allowance is a delegation of NIH’s own approval authority to the institution, not a rewrite of §200.458 — the underlying written-approval requirement is satisfied by the institution’s documented internal sign-off instead of a case-by-case NIH letter.
NSF: the NSF Proposal & Award Policies & Procedures Guide (PAPPG) sets the same 90-day window. Within it, NSF does not require a separate NSF approval as long as (1) the recipient’s own policies and procedures document the approval, and (2) the advanced spending is necessary for the effective and economical conduct of the project. Beyond 90 days, the recipient must request NSF’s approval through NSF’s electronic systems before spending occurs.

The pattern is the same in both cases: within roughly 90 days, the agency delegates its written-approval authority to the institution’s own internal control process; beyond that window, the recipient has to go back to the agency directly. Not every federal awarding agency implements §200.458 the same way. Before assuming the 90-day norm applies, check the specific agency’s own grants policy statement or equivalent implementing guidance (referenced in the notice of award or funding opportunity terms) rather than treating 90 days as a universal rule — it is the common case among large research funders, not a government-wide constant.

The institution bears the risk, not the agency

Both NIH and NSF state this explicitly, and it is the single most important operational fact on this page: pre-award costs are incurred at the recipient’s own risk. The federal awarding agency is under no obligation to reimburse pre-award spending if, for any reason, the anticipated award is never made, is delayed indefinitely, or is issued at a lower amount than expected and therefore cannot cover what was already spent. Approval — whether it’s the agency’s or the institution’s own delegated sign-off — establishes that the cost is allowable if the award materializes. It does not create any funding obligation on the agency’s part before that award exists.

This is why sponsored programs and post-award finance offices generally require a distinct internal approval step before opening an at-risk or advance account against an anticipated award — separate from, and in addition to, the §200.458 allowability question. Typical institutional practice includes:

A documented internal authorization (often requiring a department chair, dean, or vice president for research sign-off above a dollar threshold) acknowledging the department or PI’s own funds are on the hook if the award falls through.
A cap on how much can be spent at-risk, frequently well below the full anticipated award amount.
A requirement that the anticipated award be reasonably certain — e.g., a favorable summary statement, a verbal award notice from a program officer, or a fully negotiated but not-yet-executed agreement — rather than simply a submitted proposal with no funding signal at all.
A hard stop if the award is not issued within a set period, after which the account is closed and any unrecovered spending becomes an institutional or departmental cost.

None of this is dictated by §200.458 itself; it is institutional risk management built around the regulation’s core fact pattern — that a pre-award cost is allowable only if the award eventually exists, and the recipient absorbs the consequence if it doesn’t.

What kinds of costs typically qualify

Because pre-award costs still have to meet the general allowability standard, they are not a blank check to start any project activity early. The costs that most commonly qualify are ones that are directly tied to standing up the specific proposed project and would be wasteful or impossible to defer to the award start date:

Salary and effort for key personnel whose start date (a new hire, a postdoc, a research coordinator) is fixed independently of the award timeline and who are needed at project launch.
Placing orders for long-lead-time equipment or materials that would otherwise delay the start of substantive work if ordered only after the award is issued.
Finalizing a human subjects or animal care protocol (IRB/IACUC approval) that is a prerequisite to beginning the funded activity, where the review itself needs lead time.
Continuing an ongoing, previously funded activity without a gap, where a successor award is anticipated but not yet issued (distinct from starting genuinely new work).

Costs that are speculative, unrelated to the specific scope of work in the pending award, or that could reasonably wait until the award is issued are the ones most likely to draw scrutiny in a later audit or cost-allowability review — the §200.458 test is necessity for efficient and timely performance, not convenience of starting early.

Practical steps for a sponsored programs office

Confirm whether the awarding agency’s implementing policy sets an automatic pre-award window (like NIH’s and NSF’s 90 days) or requires prior written approval for any pre-award spending, regardless of how close to the anticipated start date.
If within the automatic window, route the request through the institution’s own documented approval process — this substitutes for agency approval, so it needs to actually exist on paper, not just be assumed.
If outside the window, or if the agency does not delegate approval at all, submit a written pre-award-cost request to the agency before any cost is incurred, not after.
Set up the at-risk or advance account with its own institutional approval, spending cap, and expiration trigger, separate from the §200.458 allowability sign-off.
Once the award is issued, confirm the pre-award costs are charged to the initial budget period as §200.458 requires (unless the notice of award specifies otherwise), and reconcile the at-risk account into the award account promptly.

Frequently asked questions

Does every pre-award cost need the federal agency’s own approval?

Not necessarily. §200.458 requires written agency approval, but agencies can and do delegate that approval to the institution for costs within a defined window — NIH and NSF both delegate it for costs incurred up to 90 days before the award start date, provided the institution documents its own internal approval. Outside that window, or with agencies that don’t offer the same delegation, direct written agency approval is required before the cost is incurred.

What happens if the award is never issued?

The institution absorbs the cost. Pre-award spending is explicitly at the recipient’s own risk under both NIH and NSF policy, and the federal government has no obligation to fund costs incurred in anticipation of an award that does not materialize or is issued for less than expected.

See the general funding-decision context in Sample Letter of Award (Notice of Award): Key Components and What to Check for what actually confirms an award exists.

Is the 90-day period the same for every federal agency?

No. It is a common implementation choice among large research funders (NIH, NSF), not a figure written into §200.458 itself. Always check the specific awarding agency’s grants policy statement or equivalent guidance before assuming the 90-day allowance applies.

Can indirect (F&A) costs be included in a pre-award cost request?

Pre-award costs are evaluated under the same allowability rules that would apply had they been incurred after the award start date, which generally includes appropriately allocated indirect costs at the institution’s applicable negotiated rate — but the specific award’s terms and the awarding agency’s guidance should be checked, since some funding mechanisms cap or otherwise restrict indirect cost recovery.

How is this different from Subpart C’s pre-federal-award requirements?

Subpart C (§200.200–200.211) governs the federal agency’s own pre-award administrative steps — how it announces opportunities, evaluates applications, and conducts risk review before making an award. §200.458 is a Subpart E cost-allowability provision that applies to the recipient institution, addressing whether a specific expenditure made before the award exists can later be charged to it. They cover different stages and different parties; see 2 CFR 200 Subpart C: Pre-Federal Award Requirements for the agency-side process.